financetom
COLM
financetom
/
Consumer Discretionary
/
COLM
All stocks News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Commodities
Columbia Sportswear CompanyCOLM
USD
- At close
USD
- Until the end
The complete list of US stocks
1D
5D
1M
1Y
5Y
MAX
Overview >
% Change
Description >

Columbia Sportswear Company, together with its subsidiaries, designs, sources, markets, and distributes outdoor, active, and everyday lifestyle apparel, footwear, accessories, and equipment in the United States, Latin America, the Asia Pacific, Europe, the Middle East, Africa, and Canada.

The company provides apparel, accessories, and equipment for mountaineering, climbing, skiing and snowboarding, trail, and camp enthusiasts.

It also offers footwear products that include lightweight hiking boots, trail running shoes, rugged cold weather boots for activities on snow and ice, sandals and shoes for use in water activities, and function-first fashion footwear and casual shoes for lifestyle wear.

The company sells its products under the Columbia, Mountain Hardwear, SOREL, and prAna brand names through the company owned network of branded and outlet retail stores, brand-specific e-commerce sites, and concession-based arrangements with third-parties at branded outlet and shop-in-shop retail locations, as well as through independently operated specialty outdoor and sporting goods stores, sporting goods chains, department store chains, internet retailers, and international distributors.

The company was founded in 1938 and is headquartered in Portland, Oregon.

Latest News >
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
BRIEF-Johnson & Johnson Strengthens Pipeline to Lead in Atopic Dermatitis With the Completion of the Acquisition of Yellow Jersey Therapeutics, Gaining Ownership of NM26
Jul 11, 2024
July 11 (Reuters) - Johnson & Johnson: * JOHNSON & JOHNSON STRENGTHENS PIPELINE TO LEAD IN ATOPIC DERMATITIS WITH THE COMPLETION OF THE ACQUISITION OF YELLOW JERSEY THERAPEUTICS, GAINING OWNERSHIP OF NM26 Source text for Eikon: Further company coverage: ...
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
PepsiCo quarterly revenue misses estimates as demand slows for snacks, sodas
Jul 11, 2024
July 11 (Reuters) - PepsiCo ( PEP ) missed expectations for second-quarter revenue on Thursday as a series of price hikes and competition from private-label brands slowed sales of its snacks and soda mainly in the United States, its largest market. Analysts have said that product prices, which are starting to normalize almost after two years of multiple hikes, are...
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Bitcoin Explodes Toward $60K as June CPI Numbers Favorable
Jul 11, 2024
The US Bureau of Labor Statistics (BLS) has published this months data for the Consumer Price Index. As is normally the case, this has caused some volatility within the cryptocurrency markets. In June, the CPI for all urban consumers fell 0.1%, seasonally adjusted This represents a change of 3% over the last 12 months, not seasonally adjusted. On the news,...
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Akebia Regains Full Rights to Sell Vafseo Tablets in US After Ending Licensing Deal With CSL Vifor
Jul 11, 2024
08:16 AM EDT, 07/11/2024 (MT Newswires) -- Akebia Therapeutics ( AKBA ) said Thursday that it has regained full rights to commercialize Vafseo tablets in the US after agreeing to terminate a license agreement with CSL Vifor. Akebia said it is now allowed to deal directly with all dialysis organizations effective immediately. Akebia said CSL Vifor is entitled to quarterly...
Copyright 2023-2025 - www.financetom.com All Rights Reserved